Meet the Medicine by Design Myogenesis Discussion Group

In late 2018 Louise Moyle and Dwi Kemaladewi, postdocs in skeletal muscle biology at the University of Toronto and SickKids Hospital, decided to hold a joint lab meeting for members of their research groups (led by Dr. Penney Gilbert, Dr. Ronald Cohn and Dr. James Dowling) who were also working on muscle projects. The aim of the meeting was to get to know fellow researchers in Toronto in order to start new collaborations, share techniques and bounce ideas off each other.

After two successful meetings they applied for funding as a new Medicine by Design Scientific Discussion Group, to open the group to all interested muscle researchers in the Greater Toronto Area and crucially, to provide snacks! In January 2019, the Myogenesis Discussion Group was born. Shortly afterward, Dwi left Toronto to start her own lab at the University of Pittsburgh (congrats Dwi!) so Matthew Rok and more recently Mo Zhao joined the organising team.

Over the last 4 years, the Myogenesis Discussion Group have hosted over 30 meetings, keeping to their original goal to foster an inclusive and informal research community where everyone has the opportunity to ask questions and share ideas. Since March 2020 the Myogenesis Discussion Group has moved to a virtual format, which has enabled the expansion to a truly international group, with members from across Canada, the US, Europe and even Australia! Looking forward, they hope to continue holding virtual seminars to maintain accessibility, but also bring back some in-person events to retain their community focus.

The Myogenesis Discussion Group holds virtual monthly seminars 2-3pm EST on the last Monday of every month, to promote the communication and dissemination of research within the muscle field for all aspects of muscle (skeletal, smooth and cardiac).

They aim to host a wide range of speakers within and outside of Canada from graduate student trainees and postdocs to technicians and principal investigators. Speakers will give a 20-30 minute talk followed by a discussion period with the audience. To join the Myogenesis email list, or if you are interested in speaking, please contact one of the organizers listed below and keep up-to-date via Twitter @MyogenesisGroup.

poster containing upcoming events for the myogenesis discussion group

Myogenesis Discussion Group Organizers

Dr. Louise Moyle:

 

 

 

Matthew Rok of the Myogenesis Discussion GroupMatthew Rok:

 

 

 

Dr. Mo Zhao:

 

 

 

 

MyogenesisDiscussionGroup

Read next...

Hope On The Horizon: Trials Treatments and Therapies for DMD, DM1 and MG

Hope on the Horizon: Trials, Treatments and Therapies for DMD, DM1 & MG

Nov 25-28, 2025 | Join us at Hope on the Horizon to learn more about the treatment and clinical trial landscape for Duchenne Muscular Dystrophy, Myotonic Dystrophy Type 1 and Myasthenia Gravis from key experts in the field!

Website - 2026 NMD4C Awards Now Open

2026 Awards Now Open for Nominations!

We’re proud to recognize outstanding achievements across the neuromuscular research community with our Three awards: Publication of the Year, Early Career Biomedical/Clinical Researchers of the Year.

AGAMREE (vamorolone) Approved treatment for DMD in Canada

A Milestone in Neuromuscular Care: AGAMREE® (vamorolone) Approved as the First Treatment for Duchenne Muscular Dystrophy in Canada

Health Canada has approved AGAMREE® (vamorolone), the first-ever treatment for Duchenne Muscular Dystrophy (DMD) in Canada. Patient Support Program opens for enrollment on October 10, 2025.